Synthesis and structure assignment of the minor metabolite arising from the frog pathogen Mycobacterium liflandii.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. The chemistry and biology of mycolactones.Beilstein journal of organic chemistry · 2017
   Review
2. A unified synthetic strategy to the Cryptocarya family of natural products exploiting Anion Relay Chemistry (ARC).Organic letters · 2013
   Article
3. Chemistry of mycolactones, the causative toxins of Buruli ulcer.Proceedings of the National Academy of Sciences of the United States of America · 2011
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

Abstract